Home > Insider Trading > Filing (0001209191-22-005651)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1108205	Curis Inc	CRIS	Biological Products, (No Disgnostic Substances) (2836)	043505116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1400977	E James Dentzer	C/O Curis, Inc. 128 Spring Street Building C Suite 500 Lexington MA 02421	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-01-27	2,406	$3.18	67,971	No	4	S	Direct
Common Stock	Disposition	2022-01-31	3,094	$3.07	64,877	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee stock option (right to buy)	Acquisiton	2022-01-29	825,000	$0.00	825,000	$3.09

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
825,000		2032-01-28	No	4	A	Direct

Footnotes

Shares were sold pursuant to a "sell to cover" arrangement to satisfy minimum statutory tax withholding obligations related to a vesting of a service-based restricted stock award granted on January 22, 2018.
This transaction was effected pursuant to Rule 10b5-1 trading plans to cover tax obligations.
The option grant described in this Form 4 filing vests as to 25% of the original shares on January 29, 2023 and as to an additional 6.25% of the original shares each successive quarter and until January 29, 2026.